Osivax Enters Research Collaboration with the NIAID for the Evaluation of Combination Approach to Broad-Spectrum Influenza Vaccines

IgGenix Moves Headquarters to Lilly Gateway Labs in South San Francisco

Intranasal Chlorpheniramine Maleate Effective for the Treatment of COVID-19, Study Shows

ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine Using Proprietary B-Tech Vector Platform

SHOWA strengthens domestic supply of medical PPE to ensure the US is better prepared for future pandemics

HDT Bio Demonstrates RNA Vaccines Matched to SARS-CoV2 Variants Protect Against Infection of Upper Airways, Important for Preventing Transmission

HDT Bio targets vaccines to specific variants of SARS-CoV2 to slow the spread of COVID-19 and reduce transmission

Venatorx Pharmaceuticals closes Series C financing led by the AMR Action Fund

Prestige signs MOU with Vaxine for supply of Spikogen COVID vaccine and co-development of COVID-19/influenza combo vaccine

Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine

HDT Bio Doses First Healthy Volunteer in US Phase 1 Trial of Next Generation COVID-19 Variant RNA Vaccine

HDT Bio Corp launches Phase 1 trial in vaccinated and unvaccinated people to evaluate HDT-301 as booster as well as primary vaccine

Novavax announces two booster studies to evaluate its COVID-19 Vaccine, NVX-CoV2373

Bernard Named CEO at Applied BioCode

Chimeron Bio receives NIAID's support to evaluate its lead vaccine candidate CB-106 for COVID-19